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Guest Editorial
Recognising the impact and future potential of cancer nursing: The
RECaN project and beyond
2017 is an important year in the history of the European
Oncology Nursing Society (EONS). We are proud to be a founding
member of the European CanCer Organisation (ECCO) where 24
oncology-speciﬁc professional societies share the common vision
for promoting multidisciplinary cancer care of the highest quality
in Europe. EONS itself comprises 32 member societies with mem-
bers from all across Europe. We aim to beneﬁt all our members
through the CARE working groups which concentrate on Commu-
nication, Advocacy, Research and Education. These four groups pro-
vide for the core activities of EONS and through them we aim to
extend the role and future potential of cancer nursing in Europe.
As a founding member of ECCO, EONS is also uniquely posi-
tioned to focus on consensus issues facing European nurses
engaged in cancer care. This is a core goal of the Society and in
2017 we are undertaking our ﬂagship RECaN project which, in its
ﬁrst two phases, will provide evidence of the range of nursing inter-
ventions that have employed trial methodologies, as well as
providing insight into the role and scope of cancer nursing in four
European countries. In the third phase we intend engaging with
policy-makers at local, national and European level to understand
the current situation in order to ensure that cancer nursing remains
a top priority.
EONS also plays an important role in shaping and promoting
oncopolicy through its participation in ECCO's Oncopolicy and
Oncopolicy Executive Committees. The primary aim of these com-
mittees includes setting ECCO's policy priorities and ensuring that
provision is made for all aspects of ECCO's Public Affairs activity.
The current ECCO Policy pillars of activities include: (1) Quality
Assurance & Organisation of Care, (2) Oncology Workforce and
(3) General policy monitoring and shaping. As part of these pillars,
ECCO drives both its own policy initiatives and also contributes to
EU and other stakeholder initiatives. The latter initiatives include
participation in: CANCON (Development of the European Guide
on Quality Improvement in Comprehensive Cancer Control,
https://cancercontrol.eu/archived/), the Joint Action on Rare Can-
cers (http://jointactionrarecancers.eu/), Contributions to the Euro-
pean Public Health Alliance (EPHA), Euracan e ERN (European
Reference Network) on rare cancers of adults (http://ec.europa.
eu/health/ern/networks_en) to mention a few. ECCO's own driven
initiatives include Translating Research into Care, Access to Innova-
tion, Integrated Primary and Secondary Cancer Care, and devel-
oping the Essential Requirements in Quality Cancer Care (ERQCC -
http://www.ecco-org.eu/Global/News/Latest-News/2017/02/ECCO-
Essential-Requirements-for-Quality-Cancer-Care). ECCO also sup-
ports the RECaN e Recognising cancer nursing in Europe project
that is undertaken by EONS.
Our RECaN project is a good example of oncopolicy in action and
as it consists of distinct but interrelated phases it addresses the
pathway to impact on national cancer nursing working practices
and cancer policy.
Phase I has involved a systematic review using 10 electronic da-
tabases (Medline, AMED, Epistemonikos, CINAHL, Embase, CEN-
TRAL, CDSR, DARE, HTA, WHO ICTRP) on the impact of nursing on
patient outcomes and experiences. The review has drawn on inter-
national evidence and aims to:
 Determine the effectiveness of interventions delivered by cancer
nurses in improving the experience and outcomes of patients
with cancer.
 Identify the roles and types of intervention activities that have
been performed by cancer nurses.
 Investigate whether there is a relationship between cancer
nurse education and training and patient experiences and
outcomes.
Although preceding reviews have synthesised the evidence for
speciﬁc nurse-led interventions (e.g. psychosocial and supportive
care nursing interventions in breast cancer, nurse-led interventions
involving telephone contact in women with gynaecological cancer,
etc), none of these reviews has explored the impact of cancer
nursing on patients’ experiences and outcomes across the spectrum
of cancer.
The evidence collected through Phase I will inform the Phase II
of RECaN as outlined above. This will be achieved by identifying the
potential barriers as well as facilitating factors to adopting nurse-
led interventions in clinical practice and attaining overall recogni-
tion for cancer nursing. Four European countries have been chosen
to act as case-studies; drawing on the scientiﬁc evidence from the
systematic review and from in-depth data from key persons in the
healthcare arena will allow evidence synthesis towards mapping
the successful policy pathway(s) for achieving cancer nursing
recognition. The identiﬁed countries include two where Cancer
Nursing is already recognized and developed to advanced practice
(Netherlands and UK) and two countries where Cancer Nursing is
developing towards this status (Estonia and Germany).
The ﬁnal Phase of the RECaN project will include the creation of
a “white paper” on the need for Recognising Cancer Nursing across
all European countries drawing on sources from across all three
phases and on a range of other scientiﬁc evidence. The paper will
be aimed at National and European policy makers (as well as
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pressure groups such as patient advocacy groups) aiming to com-
plement the current EU Directive 2013/55/EU. This directive pro-
vides the regulatory contextual framework on the recognition of
professional qualiﬁcations based on an established system of auto-
matic recognition across Europe for seven professions including
doctors - generalists and specialists - and nurses in general practice.
The ﬁndings from the RECaN are hoped to provide the contextual
basis for extending the EU Directive 2013/55/EU to include special-
ized cancer nursing.
The RECaN projects build on previous initiatives demonstrating
the added value of specialized and personalized cancer nursing in-
terventions and can be considered in relation to increased profes-
sional mobility, the increasing need for comparable educational
curricula, and career advancement for those wishing to specialise
in cancer care within a multidisciplinary setting.
As we carry out the RECaN project we are aware of the rising
global demand of cancer and the need for well-educated and moti-
vated nurses to address the (often complex) needs of more and
more patients. If we do not recognize the value of cancer nursing
at the policy level (and also in terms of employment practices
and education opportunities) then we risk simply not having the
quality nurses needed to meet the cancer burden.
Cancer nurses are now a global commodity and more nurses are
choosing to work in other countries where career opportunities
may be better. This has implications for the host country, as well
the countries they are moving from. An example of this is contained
in a recent report by NHS Employers who noted that in 2015 more
than 60% of the UK's NHS Trusts had actively recruited nurses from
outside the UK, and 55% were now considering doing so.
In this climate it is important to recognize the contribution that
cancer nurses make and to ensure that their potential is maximized
in whatever health economy they are employed in. In May 2017
EONS launched its ﬁrst European Cancer Nursing Day (https://
www.europeancancernursingday.com/) to establish a strong
network of awareness about the value of nursing in this context.
Its success was captured on social media and emphasized the sense
of cohesion and pride that exists in nurses caring for people with a
cancer diagnosis.
We look forward to building on this event with the empirical
ﬁndings of the RECaN project and look forward to sharing these
with colleagues around the world.
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